Skip to the page

Data / Drug companies / Vitamin D Analog

Vitamin D Analog drugs: 4 drugs from 19 companies in the FDA NDC directory

Vitamin D Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 49 products in this class from 19 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 19Companies
  • 49Products
  • 4Drugs by generic name

Drugs in the Vitamin D Analog class

Ranked by number of companies that list the drug.

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
AbbVie Inc.4injection, solution; capsule, liquid filledNew drug applications (NDA)April 20, 2018
Amneal Pharmaceuticals LLC4injectionGeneric drugs (ANDA)March 9, 2017
Bryant Ranch Prepack4capsule; ointmentGeneric drugs (ANDA)January 30, 2020
Eugia US LLC4injectionGeneric drugs (ANDA)October 9, 2018
Amneal Pharmaceuticals LLC3capsuleGeneric drugs (ANDA)January 15, 2016
Aurobindo Pharma Limited3capsule, liquid filledGeneric drugs (ANDA)January 14, 2016
Bionpharma Inc.3capsuleGeneric drugs (ANDA)August 16, 2016
Bryant Ranch Prepack3capsule; ointmentGeneric drugs (ANDA)January 30, 2020
Prasco Laboratories3ointment; creamAuthorized generics (NDA)January 28, 2020
Sun Pharmaceutical Industries, Inc.3ointment; suspensionGeneric drugs (ANDA)September 2, 2020
Accord Healthcare Inc.2injection, solutionNew drug applications (NDA)March 24, 2016
Cosette Pharmaceuticals, Inc.2solution; suspensionGeneric drugs (ANDA)August 2, 2024
Glenmark Pharmaceuticals Inc., USA2cream; ointmentGeneric drugs (ANDA)June 10, 2015
Leo Pharma Inc.2suspension; aerosol, foamNew drug applications (NDA)October 16, 2015
Mayne Pharma Inc.2aerosol, foamNew drug applications (NDA)February 15, 2021
Perfero Pharma, Inc.2solutionGeneric drugs (ANDA)June 1, 2026
MC2 Therapeutics Ltd1creamNew drug applications (NDA)June 30, 2021
NorthStar Rx LLC1creamGeneric drugs (ANDA)June 1, 2015
Padagis Israel Pharmaceuticals Ltd1ointmentGeneric drugs (ANDA)January 30, 2020

Dosage forms

Dosage formProductsShare
Capsule1020.4%
Ointment918.4%
Injection816.3%
Capsule, liquid filled510.2%
Injection, solution48.2%
Cream48.2%
Solution36.1%
Suspension36.1%
Aerosol, foam36.1%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.